Global Suvorexant Tablet Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Suvorexant Tablet market size was valued at US$ 376 million in 2025 and is forecast to a readjusted size of US$ 270 million by 2032 with a CAGR of -4.7% during review period.
Suvorexant (brand name Belsomra) is a prescription medication used to treat insomnia, specifically helping adults fall asleep faster and stay asleep longer. It acts as a dual orexin receptor antagonist, blocking chemicals in the brain that promote wakefulness. It is taken orally, typically at a dose of 10-20 mg, 30 minutes before bed.
In 2025, the global production of Suvoresin tablets is 46.2 million tablets, with an average price of US$7.9 per tablet and an average gross profit margin of 81%.
Based on our research, the suvorexant market should be characterized as a highly focused single-molecule prescription drug market rather than a broad insomnia treatment segment. The appropriate scope is limited to finished oral tablets containing suvorexant and its associated supply chain, excluding other DORA drugs and traditional hypnotics. From a product perspective, suvorexant represents the first commercially successful dual orexin receptor antagonist, but its commercial performance remains heavily dependent on the BELSOMRA franchise rather than a multi-manufacturer expansion model.
From a supply structure standpoint, the finished dosage market remains highly concentrated, with Merck/MSD as the dominant player. Regional entities in Japan and Australia operate under the same corporate system, reinforcing the centralized nature of the finished drug segment. In contrast, the upstream API and intermediate supply chain is more diversified, with increasing participation from Chinese companies, particularly in custom synthesis, intermediate manufacturing, and potential generic pathways. This creates a dual-layer structure characterized by concentrated downstream commercialization and fragmented upstream supply.
From a demand perspective, suvorexant faces both structural support and competitive pressure. The DORA mechanism offers clinical advantages over traditional hypnotics, supporting its role in premium insomnia treatment. However, competing products such as lemborexant and daridorexant exert direct pressure on market share. As a result, while baseline demand is expected to remain stable, pricing dynamics and revenue growth are likely to weaken over time.
From a regulatory perspective, suvorexant operates under stricter frameworks compared to standard oral drugs, including controlled substance classification in the United States and additional prescription controls in other regions. These regulatory factors increase entry barriers for generics and suppliers, requiring not only chemical manufacturing capability but also compliance with regulatory, quality, and distribution requirements. Over time, the industry is expected to evolve from a single-originator model to a layered ecosystem involving originators, generic entrants, API suppliers, and specialized intermediate manufacturers.
This report is a detailed and comprehensive analysis for global Suvorexant Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Suvorexant Tablet market size and forecasts, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
Global Suvorexant Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
Global Suvorexant Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
Global Suvorexant Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (K Tablets), and ASP (US$/Tablet), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Suvorexant Tablet market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Suvorexant (brand name Belsomra) is a prescription medication used to treat insomnia, specifically helping adults fall asleep faster and stay asleep longer. It acts as a dual orexin receptor antagonist, blocking chemicals in the brain that promote wakefulness. It is taken orally, typically at a dose of 10-20 mg, 30 minutes before bed.
In 2025, the global production of Suvoresin tablets is 46.2 million tablets, with an average price of US$7.9 per tablet and an average gross profit margin of 81%.
Based on our research, the suvorexant market should be characterized as a highly focused single-molecule prescription drug market rather than a broad insomnia treatment segment. The appropriate scope is limited to finished oral tablets containing suvorexant and its associated supply chain, excluding other DORA drugs and traditional hypnotics. From a product perspective, suvorexant represents the first commercially successful dual orexin receptor antagonist, but its commercial performance remains heavily dependent on the BELSOMRA franchise rather than a multi-manufacturer expansion model.
From a supply structure standpoint, the finished dosage market remains highly concentrated, with Merck/MSD as the dominant player. Regional entities in Japan and Australia operate under the same corporate system, reinforcing the centralized nature of the finished drug segment. In contrast, the upstream API and intermediate supply chain is more diversified, with increasing participation from Chinese companies, particularly in custom synthesis, intermediate manufacturing, and potential generic pathways. This creates a dual-layer structure characterized by concentrated downstream commercialization and fragmented upstream supply.
From a demand perspective, suvorexant faces both structural support and competitive pressure. The DORA mechanism offers clinical advantages over traditional hypnotics, supporting its role in premium insomnia treatment. However, competing products such as lemborexant and daridorexant exert direct pressure on market share. As a result, while baseline demand is expected to remain stable, pricing dynamics and revenue growth are likely to weaken over time.
From a regulatory perspective, suvorexant operates under stricter frameworks compared to standard oral drugs, including controlled substance classification in the United States and additional prescription controls in other regions. These regulatory factors increase entry barriers for generics and suppliers, requiring not only chemical manufacturing capability but also compliance with regulatory, quality, and distribution requirements. Over time, the industry is expected to evolve from a single-originator model to a layered ecosystem involving originators, generic entrants, API suppliers, and specialized intermediate manufacturers.
This report is a detailed and comprehensive analysis for global Suvorexant Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Suvorexant Tablet market size and forecasts, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
Global Suvorexant Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
Global Suvorexant Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Tablets), and average selling prices (US$/Tablet), 2021-2032
Global Suvorexant Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (K Tablets), and ASP (US$/Tablet), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Suvorexant Tablet
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Suvorexant Tablet market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- 5 mg Tablets
- 10 mg Tablets
- 15 mg Tablets
- 20 mg Tablets
- Other
- Approved Originator Product
- Approved Generic Product
- Generic Under Filing
- Sleep Onset Insomnia
- Sleep Maintenance Insomnia
- Mixed Insomnia
- Clinical Research
- Other
- Merck & Co.
- MSD K.K.
- Merck Sharp & Dohme (Australia)
- Axplora Group
- Zhejiang Huahai Pharmaceutical
- Apino Pharma
- Guangzhou Green Cross Pharmaceutical
- Sandoo Pharmaceuticals and Chemicals
- Nanjing Wedo Pharmatech
- Unibest Industrial
- Taizhou Sci-Healthoo Pharmaceutical Technology
- Shanghai Haoyuan Chemexpress
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
- Chapter 1, to describe Suvorexant Tablet product scope, market overview, market estimation caveats and base year.
- Chapter 2, to profile the top manufacturers of Suvorexant Tablet, with price, sales quantity, revenue, and global market share of Suvorexant Tablet from 2021 to 2026.
- Chapter 3, the Suvorexant Tablet competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
- Chapter 4, the Suvorexant Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
- Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
- Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Suvorexant Tablet market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
- Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
- Chapter 13, the key raw materials and key suppliers, and industry chain of Suvorexant Tablet.
- Chapter 14 and 15, to describe Suvorexant Tablet sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Suvorexant Tablet Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 5 mg Tablets
1.3.3 10 mg Tablets
1.3.4 15 mg Tablets
1.3.5 20 mg Tablets
1.3.6 Other
1.4 Market Analysis by Regulatory Status
1.4.1 Overview: Global Suvorexant Tablet Consumption Value by Regulatory Status: 2021 Versus 2025 Versus 2032
1.4.2 Approved Originator Product
1.4.3 Approved Generic Product
1.4.4 Generic Under Filing
1.5 Market Analysis by Application
1.5.1 Overview: Global Suvorexant Tablet Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Sleep Onset Insomnia
1.5.3 Sleep Maintenance Insomnia
1.5.4 Mixed Insomnia
1.5.5 Clinical Research
1.5.6 Other
1.6 Global Suvorexant Tablet Market Size & Forecast
1.6.1 Global Suvorexant Tablet Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Suvorexant Tablet Sales Quantity (2021-2032)
1.6.3 Global Suvorexant Tablet Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Suvorexant Tablet Product and Services
2.1.4 Merck & Co. Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Merck & Co. Recent Developments/Updates
2.2 MSD K.K.
2.2.1 MSD K.K. Details
2.2.2 MSD K.K. Major Business
2.2.3 MSD K.K. Suvorexant Tablet Product and Services
2.2.4 MSD K.K. Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 MSD K.K. Recent Developments/Updates
2.3 Merck Sharp & Dohme (Australia)
2.3.1 Merck Sharp & Dohme (Australia) Details
2.3.2 Merck Sharp & Dohme (Australia) Major Business
2.3.3 Merck Sharp & Dohme (Australia) Suvorexant Tablet Product and Services
2.3.4 Merck Sharp & Dohme (Australia) Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Merck Sharp & Dohme (Australia) Recent Developments/Updates
2.4 Axplora Group
2.4.1 Axplora Group Details
2.4.2 Axplora Group Major Business
2.4.3 Axplora Group Suvorexant Tablet Product and Services
2.4.4 Axplora Group Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Axplora Group Recent Developments/Updates
2.5 Zhejiang Huahai Pharmaceutical
2.5.1 Zhejiang Huahai Pharmaceutical Details
2.5.2 Zhejiang Huahai Pharmaceutical Major Business
2.5.3 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Product and Services
2.5.4 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
2.6 Apino Pharma
2.6.1 Apino Pharma Details
2.6.2 Apino Pharma Major Business
2.6.3 Apino Pharma Suvorexant Tablet Product and Services
2.6.4 Apino Pharma Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Apino Pharma Recent Developments/Updates
2.7 Guangzhou Green Cross Pharmaceutical
2.7.1 Guangzhou Green Cross Pharmaceutical Details
2.7.2 Guangzhou Green Cross Pharmaceutical Major Business
2.7.3 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Product and Services
2.7.4 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Guangzhou Green Cross Pharmaceutical Recent Developments/Updates
2.8 Sandoo Pharmaceuticals and Chemicals
2.8.1 Sandoo Pharmaceuticals and Chemicals Details
2.8.2 Sandoo Pharmaceuticals and Chemicals Major Business
2.8.3 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Product and Services
2.8.4 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
2.9 Nanjing Wedo Pharmatech
2.9.1 Nanjing Wedo Pharmatech Details
2.9.2 Nanjing Wedo Pharmatech Major Business
2.9.3 Nanjing Wedo Pharmatech Suvorexant Tablet Product and Services
2.9.4 Nanjing Wedo Pharmatech Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Nanjing Wedo Pharmatech Recent Developments/Updates
2.10 Unibest Industrial
2.10.1 Unibest Industrial Details
2.10.2 Unibest Industrial Major Business
2.10.3 Unibest Industrial Suvorexant Tablet Product and Services
2.10.4 Unibest Industrial Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Unibest Industrial Recent Developments/Updates
2.11 Taizhou Sci-Healthoo Pharmaceutical Technology
2.11.1 Taizhou Sci-Healthoo Pharmaceutical Technology Details
2.11.2 Taizhou Sci-Healthoo Pharmaceutical Technology Major Business
2.11.3 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Product and Services
2.11.4 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Taizhou Sci-Healthoo Pharmaceutical Technology Recent Developments/Updates
2.12 Shanghai Haoyuan Chemexpress
2.12.1 Shanghai Haoyuan Chemexpress Details
2.12.2 Shanghai Haoyuan Chemexpress Major Business
2.12.3 Shanghai Haoyuan Chemexpress Suvorexant Tablet Product and Services
2.12.4 Shanghai Haoyuan Chemexpress Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Shanghai Haoyuan Chemexpress Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SUVOREXANT TABLET BY MANUFACTURER
3.1 Global Suvorexant Tablet Sales Quantity by Manufacturer (2021-2026)
3.2 Global Suvorexant Tablet Revenue by Manufacturer (2021-2026)
3.3 Global Suvorexant Tablet Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Suvorexant Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Suvorexant Tablet Manufacturer Market Share in 2025
3.4.3 Top 6 Suvorexant Tablet Manufacturer Market Share in 2025
3.5 Suvorexant Tablet Market: Overall Company Footprint Analysis
3.5.1 Suvorexant Tablet Market: Region Footprint
3.5.2 Suvorexant Tablet Market: Company Product Type Footprint
3.5.3 Suvorexant Tablet Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Suvorexant Tablet Market Size by Region
4.1.1 Global Suvorexant Tablet Sales Quantity by Region (2021-2032)
4.1.2 Global Suvorexant Tablet Consumption Value by Region (2021-2032)
4.1.3 Global Suvorexant Tablet Average Price by Region (2021-2032)
4.2 North America Suvorexant Tablet Consumption Value (2021-2032)
4.3 Europe Suvorexant Tablet Consumption Value (2021-2032)
4.4 Asia-Pacific Suvorexant Tablet Consumption Value (2021-2032)
4.5 South America Suvorexant Tablet Consumption Value (2021-2032)
4.6 Middle East & Africa Suvorexant Tablet Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Suvorexant Tablet Sales Quantity by Type (2021-2032)
5.2 Global Suvorexant Tablet Consumption Value by Type (2021-2032)
5.3 Global Suvorexant Tablet Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Suvorexant Tablet Sales Quantity by Application (2021-2032)
6.2 Global Suvorexant Tablet Consumption Value by Application (2021-2032)
6.3 Global Suvorexant Tablet Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Suvorexant Tablet Sales Quantity by Type (2021-2032)
7.2 North America Suvorexant Tablet Sales Quantity by Application (2021-2032)
7.3 North America Suvorexant Tablet Market Size by Country
7.3.1 North America Suvorexant Tablet Sales Quantity by Country (2021-2032)
7.3.2 North America Suvorexant Tablet Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Suvorexant Tablet Sales Quantity by Type (2021-2032)
8.2 Europe Suvorexant Tablet Sales Quantity by Application (2021-2032)
8.3 Europe Suvorexant Tablet Market Size by Country
8.3.1 Europe Suvorexant Tablet Sales Quantity by Country (2021-2032)
8.3.2 Europe Suvorexant Tablet Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Suvorexant Tablet Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Suvorexant Tablet Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Suvorexant Tablet Market Size by Region
9.3.1 Asia-Pacific Suvorexant Tablet Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Suvorexant Tablet Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Suvorexant Tablet Sales Quantity by Type (2021-2032)
10.2 South America Suvorexant Tablet Sales Quantity by Application (2021-2032)
10.3 South America Suvorexant Tablet Market Size by Country
10.3.1 South America Suvorexant Tablet Sales Quantity by Country (2021-2032)
10.3.2 South America Suvorexant Tablet Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Suvorexant Tablet Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Suvorexant Tablet Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Suvorexant Tablet Market Size by Country
11.3.1 Middle East & Africa Suvorexant Tablet Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Suvorexant Tablet Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Suvorexant Tablet Market Drivers
12.2 Suvorexant Tablet Market Restraints
12.3 Suvorexant Tablet Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Suvorexant Tablet and Key Manufacturers
13.2 Manufacturing Costs Percentage of Suvorexant Tablet
13.3 Suvorexant Tablet Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Suvorexant Tablet Typical Distributors
14.3 Suvorexant Tablet Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Suvorexant Tablet Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 5 mg Tablets
1.3.3 10 mg Tablets
1.3.4 15 mg Tablets
1.3.5 20 mg Tablets
1.3.6 Other
1.4 Market Analysis by Regulatory Status
1.4.1 Overview: Global Suvorexant Tablet Consumption Value by Regulatory Status: 2021 Versus 2025 Versus 2032
1.4.2 Approved Originator Product
1.4.3 Approved Generic Product
1.4.4 Generic Under Filing
1.5 Market Analysis by Application
1.5.1 Overview: Global Suvorexant Tablet Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.5.2 Sleep Onset Insomnia
1.5.3 Sleep Maintenance Insomnia
1.5.4 Mixed Insomnia
1.5.5 Clinical Research
1.5.6 Other
1.6 Global Suvorexant Tablet Market Size & Forecast
1.6.1 Global Suvorexant Tablet Consumption Value (2021 & 2025 & 2032)
1.6.2 Global Suvorexant Tablet Sales Quantity (2021-2032)
1.6.3 Global Suvorexant Tablet Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Suvorexant Tablet Product and Services
2.1.4 Merck & Co. Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Merck & Co. Recent Developments/Updates
2.2 MSD K.K.
2.2.1 MSD K.K. Details
2.2.2 MSD K.K. Major Business
2.2.3 MSD K.K. Suvorexant Tablet Product and Services
2.2.4 MSD K.K. Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 MSD K.K. Recent Developments/Updates
2.3 Merck Sharp & Dohme (Australia)
2.3.1 Merck Sharp & Dohme (Australia) Details
2.3.2 Merck Sharp & Dohme (Australia) Major Business
2.3.3 Merck Sharp & Dohme (Australia) Suvorexant Tablet Product and Services
2.3.4 Merck Sharp & Dohme (Australia) Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Merck Sharp & Dohme (Australia) Recent Developments/Updates
2.4 Axplora Group
2.4.1 Axplora Group Details
2.4.2 Axplora Group Major Business
2.4.3 Axplora Group Suvorexant Tablet Product and Services
2.4.4 Axplora Group Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Axplora Group Recent Developments/Updates
2.5 Zhejiang Huahai Pharmaceutical
2.5.1 Zhejiang Huahai Pharmaceutical Details
2.5.2 Zhejiang Huahai Pharmaceutical Major Business
2.5.3 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Product and Services
2.5.4 Zhejiang Huahai Pharmaceutical Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates
2.6 Apino Pharma
2.6.1 Apino Pharma Details
2.6.2 Apino Pharma Major Business
2.6.3 Apino Pharma Suvorexant Tablet Product and Services
2.6.4 Apino Pharma Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Apino Pharma Recent Developments/Updates
2.7 Guangzhou Green Cross Pharmaceutical
2.7.1 Guangzhou Green Cross Pharmaceutical Details
2.7.2 Guangzhou Green Cross Pharmaceutical Major Business
2.7.3 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Product and Services
2.7.4 Guangzhou Green Cross Pharmaceutical Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Guangzhou Green Cross Pharmaceutical Recent Developments/Updates
2.8 Sandoo Pharmaceuticals and Chemicals
2.8.1 Sandoo Pharmaceuticals and Chemicals Details
2.8.2 Sandoo Pharmaceuticals and Chemicals Major Business
2.8.3 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Product and Services
2.8.4 Sandoo Pharmaceuticals and Chemicals Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
2.9 Nanjing Wedo Pharmatech
2.9.1 Nanjing Wedo Pharmatech Details
2.9.2 Nanjing Wedo Pharmatech Major Business
2.9.3 Nanjing Wedo Pharmatech Suvorexant Tablet Product and Services
2.9.4 Nanjing Wedo Pharmatech Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Nanjing Wedo Pharmatech Recent Developments/Updates
2.10 Unibest Industrial
2.10.1 Unibest Industrial Details
2.10.2 Unibest Industrial Major Business
2.10.3 Unibest Industrial Suvorexant Tablet Product and Services
2.10.4 Unibest Industrial Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Unibest Industrial Recent Developments/Updates
2.11 Taizhou Sci-Healthoo Pharmaceutical Technology
2.11.1 Taizhou Sci-Healthoo Pharmaceutical Technology Details
2.11.2 Taizhou Sci-Healthoo Pharmaceutical Technology Major Business
2.11.3 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Product and Services
2.11.4 Taizhou Sci-Healthoo Pharmaceutical Technology Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Taizhou Sci-Healthoo Pharmaceutical Technology Recent Developments/Updates
2.12 Shanghai Haoyuan Chemexpress
2.12.1 Shanghai Haoyuan Chemexpress Details
2.12.2 Shanghai Haoyuan Chemexpress Major Business
2.12.3 Shanghai Haoyuan Chemexpress Suvorexant Tablet Product and Services
2.12.4 Shanghai Haoyuan Chemexpress Suvorexant Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Shanghai Haoyuan Chemexpress Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: SUVOREXANT TABLET BY MANUFACTURER
3.1 Global Suvorexant Tablet Sales Quantity by Manufacturer (2021-2026)
3.2 Global Suvorexant Tablet Revenue by Manufacturer (2021-2026)
3.3 Global Suvorexant Tablet Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Suvorexant Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Suvorexant Tablet Manufacturer Market Share in 2025
3.4.3 Top 6 Suvorexant Tablet Manufacturer Market Share in 2025
3.5 Suvorexant Tablet Market: Overall Company Footprint Analysis
3.5.1 Suvorexant Tablet Market: Region Footprint
3.5.2 Suvorexant Tablet Market: Company Product Type Footprint
3.5.3 Suvorexant Tablet Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Suvorexant Tablet Market Size by Region
4.1.1 Global Suvorexant Tablet Sales Quantity by Region (2021-2032)
4.1.2 Global Suvorexant Tablet Consumption Value by Region (2021-2032)
4.1.3 Global Suvorexant Tablet Average Price by Region (2021-2032)
4.2 North America Suvorexant Tablet Consumption Value (2021-2032)
4.3 Europe Suvorexant Tablet Consumption Value (2021-2032)
4.4 Asia-Pacific Suvorexant Tablet Consumption Value (2021-2032)
4.5 South America Suvorexant Tablet Consumption Value (2021-2032)
4.6 Middle East & Africa Suvorexant Tablet Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global Suvorexant Tablet Sales Quantity by Type (2021-2032)
5.2 Global Suvorexant Tablet Consumption Value by Type (2021-2032)
5.3 Global Suvorexant Tablet Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Suvorexant Tablet Sales Quantity by Application (2021-2032)
6.2 Global Suvorexant Tablet Consumption Value by Application (2021-2032)
6.3 Global Suvorexant Tablet Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America Suvorexant Tablet Sales Quantity by Type (2021-2032)
7.2 North America Suvorexant Tablet Sales Quantity by Application (2021-2032)
7.3 North America Suvorexant Tablet Market Size by Country
7.3.1 North America Suvorexant Tablet Sales Quantity by Country (2021-2032)
7.3.2 North America Suvorexant Tablet Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe Suvorexant Tablet Sales Quantity by Type (2021-2032)
8.2 Europe Suvorexant Tablet Sales Quantity by Application (2021-2032)
8.3 Europe Suvorexant Tablet Market Size by Country
8.3.1 Europe Suvorexant Tablet Sales Quantity by Country (2021-2032)
8.3.2 Europe Suvorexant Tablet Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific Suvorexant Tablet Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Suvorexant Tablet Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Suvorexant Tablet Market Size by Region
9.3.1 Asia-Pacific Suvorexant Tablet Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific Suvorexant Tablet Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America Suvorexant Tablet Sales Quantity by Type (2021-2032)
10.2 South America Suvorexant Tablet Sales Quantity by Application (2021-2032)
10.3 South America Suvorexant Tablet Market Size by Country
10.3.1 South America Suvorexant Tablet Sales Quantity by Country (2021-2032)
10.3.2 South America Suvorexant Tablet Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Suvorexant Tablet Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Suvorexant Tablet Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Suvorexant Tablet Market Size by Country
11.3.1 Middle East & Africa Suvorexant Tablet Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa Suvorexant Tablet Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 Suvorexant Tablet Market Drivers
12.2 Suvorexant Tablet Market Restraints
12.3 Suvorexant Tablet Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Suvorexant Tablet and Key Manufacturers
13.2 Manufacturing Costs Percentage of Suvorexant Tablet
13.3 Suvorexant Tablet Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Suvorexant Tablet Typical Distributors
14.3 Suvorexant Tablet Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global SuvorexantTablet Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global SuvorexantTablet Consumption Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Table 3. Global SuvorexantTablet Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 5. Merck & Co. Major Business
Table 6. Merck & Co. SuvorexantTablet Product and Services
Table 7. Merck & Co. SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Merck & Co. Recent Developments/Updates
Table 9. MSD K.K. Basic Information, Manufacturing Base and Competitors
Table 10. MSD K.K. Major Business
Table 11. MSD K.K. SuvorexantTablet Product and Services
Table 12. MSD K.K. SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. MSD K.K. Recent Developments/Updates
Table 14. Merck Sharp & Dohme (Australia) Basic Information, Manufacturing Base and Competitors
Table 15. Merck Sharp & Dohme (Australia) Major Business
Table 16. Merck Sharp & Dohme (Australia) SuvorexantTablet Product and Services
Table 17. Merck Sharp & Dohme (Australia) SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Merck Sharp & Dohme (Australia) Recent Developments/Updates
Table 19. Axplora Group Basic Information, Manufacturing Base and Competitors
Table 20. Axplora Group Major Business
Table 21. Axplora Group SuvorexantTablet Product and Services
Table 22. Axplora Group SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Axplora Group Recent Developments/Updates
Table 24. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 25. Zhejiang Huahai Pharmaceutical Major Business
Table 26. Zhejiang Huahai Pharmaceutical SuvorexantTablet Product and Services
Table 27. Zhejiang Huahai Pharmaceutical SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 29. Apino Pharma Basic Information, Manufacturing Base and Competitors
Table 30. Apino Pharma Major Business
Table 31. Apino Pharma SuvorexantTablet Product and Services
Table 32. Apino Pharma SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Apino Pharma Recent Developments/Updates
Table 34. Guangzhou Green Cross Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 35. Guangzhou Green Cross Pharmaceutical Major Business
Table 36. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Product and Services
Table 37. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Guangzhou Green Cross Pharmaceutical Recent Developments/Updates
Table 39. Sandoo Pharmaceuticals and Chemicals Basic Information, Manufacturing Base and Competitors
Table 40. Sandoo Pharmaceuticals and Chemicals Major Business
Table 41. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Product and Services
Table 42. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
Table 44. Nanjing Wedo Pharmatech Basic Information, Manufacturing Base and Competitors
Table 45. Nanjing Wedo Pharmatech Major Business
Table 46. Nanjing Wedo Pharmatech SuvorexantTablet Product and Services
Table 47. Nanjing Wedo Pharmatech SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Nanjing Wedo Pharmatech Recent Developments/Updates
Table 49. Unibest Industrial Basic Information, Manufacturing Base and Competitors
Table 50. Unibest Industrial Major Business
Table 51. Unibest Industrial SuvorexantTablet Product and Services
Table 52. Unibest Industrial SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Unibest Industrial Recent Developments/Updates
Table 54. Taizhou Sci-Healthoo Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 55. Taizhou Sci-Healthoo Pharmaceutical Technology Major Business
Table 56. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Product and Services
Table 57. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Taizhou Sci-Healthoo Pharmaceutical Technology Recent Developments/Updates
Table 59. Shanghai Haoyuan Chemexpress Basic Information, Manufacturing Base and Competitors
Table 60. Shanghai Haoyuan Chemexpress Major Business
Table 61. Shanghai Haoyuan Chemexpress SuvorexantTablet Product and Services
Table 62. Shanghai Haoyuan Chemexpress SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Shanghai Haoyuan Chemexpress Recent Developments/Updates
Table 64. Global SuvorexantTablet Sales Quantity by Manufacturer (2021-2026) & (KTablets)
Table 65. Global SuvorexantTablet Revenue by Manufacturer (2021-2026) & (USD Million)
Table 66. Global SuvorexantTablet Average Price by Manufacturer (2021-2026) & (US$/Tablet)
Table 67. Market Position of Manufacturers in SuvorexantTablet, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 68. Head Office and SuvorexantTablet Production Site of Key Manufacturer
Table 69. SuvorexantTablet Market: Company Product Type Footprint
Table 70. SuvorexantTablet Market: Company Product Application Footprint
Table 71. SuvorexantTablet New Market Entrants and Barriers to Market Entry
Table 72. SuvorexantTablet Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global SuvorexantTablet Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 74. Global SuvorexantTablet Sales Quantity by Region (2021-2026) & (KTablets)
Table 75. Global SuvorexantTablet Sales Quantity by Region (2027-2032) & (KTablets)
Table 76. Global SuvorexantTablet Consumption Value by Region (2021-2026) & (USD Million)
Table 77. Global SuvorexantTablet Consumption Value by Region (2027-2032) & (USD Million)
Table 78. Global SuvorexantTablet Average Price by Region (2021-2026) & (US$/Tablet)
Table 79. Global SuvorexantTablet Average Price by Region (2027-2032) & (US$/Tablet)
Table 80. Global SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 81. Global SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 82. Global SuvorexantTablet Consumption Value by Type (2021-2026) & (USD Million)
Table 83. Global SuvorexantTablet Consumption Value by Type (2027-2032) & (USD Million)
Table 84. Global SuvorexantTablet Average Price by Type (2021-2026) & (US$/Tablet)
Table 85. Global SuvorexantTablet Average Price by Type (2027-2032) & (US$/Tablet)
Table 86. Global SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 87. Global SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 88. Global SuvorexantTablet Consumption Value by Application (2021-2026) & (USD Million)
Table 89. Global SuvorexantTablet Consumption Value by Application (2027-2032) & (USD Million)
Table 90. Global SuvorexantTablet Average Price by Application (2021-2026) & (US$/Tablet)
Table 91. Global SuvorexantTablet Average Price by Application (2027-2032) & (US$/Tablet)
Table 92. North America SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 93. North America SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 94. North America SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 95. North America SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 96. North America SuvorexantTablet Sales Quantity by Country (2021-2026) & (KTablets)
Table 97. North America SuvorexantTablet Sales Quantity by Country (2027-2032) & (KTablets)
Table 98. North America SuvorexantTablet Consumption Value by Country (2021-2026) & (USD Million)
Table 99. North America SuvorexantTablet Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Europe SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 101. Europe SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 102. Europe SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 103. Europe SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 104. Europe SuvorexantTablet Sales Quantity by Country (2021-2026) & (KTablets)
Table 105. Europe SuvorexantTablet Sales Quantity by Country (2027-2032) & (KTablets)
Table 106. Europe SuvorexantTablet Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Europe SuvorexantTablet Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Asia-Pacific SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 109. Asia-Pacific SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 110. Asia-Pacific SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 111. Asia-Pacific SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 112. Asia-Pacific SuvorexantTablet Sales Quantity by Region (2021-2026) & (KTablets)
Table 113. Asia-Pacific SuvorexantTablet Sales Quantity by Region (2027-2032) & (KTablets)
Table 114. Asia-Pacific SuvorexantTablet Consumption Value by Region (2021-2026) & (USD Million)
Table 115. Asia-Pacific SuvorexantTablet Consumption Value by Region (2027-2032) & (USD Million)
Table 116. South America SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 117. South America SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 118. South America SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 119. South America SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 120. South America SuvorexantTablet Sales Quantity by Country (2021-2026) & (KTablets)
Table 121. South America SuvorexantTablet Sales Quantity by Country (2027-2032) & (KTablets)
Table 122. South America SuvorexantTablet Consumption Value by Country (2021-2026) & (USD Million)
Table 123. South America SuvorexantTablet Consumption Value by Country (2027-2032) & (USD Million)
Table 124. Middle East & Africa SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 125. Middle East & Africa SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 126. Middle East & Africa SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 127. Middle East & Africa SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 128. Middle East & Africa SuvorexantTablet Sales Quantity by Country (2021-2026) & (KTablets)
Table 129. Middle East & Africa SuvorexantTablet Sales Quantity by Country (2027-2032) & (KTablets)
Table 130. Middle East & Africa SuvorexantTablet Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Middle East & Africa SuvorexantTablet Consumption Value by Country (2027-2032) & (USD Million)
Table 132. SuvorexantTablet Raw Material
Table 133. Key Manufacturers of SuvorexantTablet Raw Materials
Table 134. SuvorexantTablet Typical Distributors
Table 135. SuvorexantTablet Typical Customers
Table 1. Global SuvorexantTablet Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global SuvorexantTablet Consumption Value by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Table 3. Global SuvorexantTablet Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 5. Merck & Co. Major Business
Table 6. Merck & Co. SuvorexantTablet Product and Services
Table 7. Merck & Co. SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 8. Merck & Co. Recent Developments/Updates
Table 9. MSD K.K. Basic Information, Manufacturing Base and Competitors
Table 10. MSD K.K. Major Business
Table 11. MSD K.K. SuvorexantTablet Product and Services
Table 12. MSD K.K. SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 13. MSD K.K. Recent Developments/Updates
Table 14. Merck Sharp & Dohme (Australia) Basic Information, Manufacturing Base and Competitors
Table 15. Merck Sharp & Dohme (Australia) Major Business
Table 16. Merck Sharp & Dohme (Australia) SuvorexantTablet Product and Services
Table 17. Merck Sharp & Dohme (Australia) SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 18. Merck Sharp & Dohme (Australia) Recent Developments/Updates
Table 19. Axplora Group Basic Information, Manufacturing Base and Competitors
Table 20. Axplora Group Major Business
Table 21. Axplora Group SuvorexantTablet Product and Services
Table 22. Axplora Group SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 23. Axplora Group Recent Developments/Updates
Table 24. Zhejiang Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 25. Zhejiang Huahai Pharmaceutical Major Business
Table 26. Zhejiang Huahai Pharmaceutical SuvorexantTablet Product and Services
Table 27. Zhejiang Huahai Pharmaceutical SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 28. Zhejiang Huahai Pharmaceutical Recent Developments/Updates
Table 29. Apino Pharma Basic Information, Manufacturing Base and Competitors
Table 30. Apino Pharma Major Business
Table 31. Apino Pharma SuvorexantTablet Product and Services
Table 32. Apino Pharma SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 33. Apino Pharma Recent Developments/Updates
Table 34. Guangzhou Green Cross Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 35. Guangzhou Green Cross Pharmaceutical Major Business
Table 36. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Product and Services
Table 37. Guangzhou Green Cross Pharmaceutical SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 38. Guangzhou Green Cross Pharmaceutical Recent Developments/Updates
Table 39. Sandoo Pharmaceuticals and Chemicals Basic Information, Manufacturing Base and Competitors
Table 40. Sandoo Pharmaceuticals and Chemicals Major Business
Table 41. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Product and Services
Table 42. Sandoo Pharmaceuticals and Chemicals SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 43. Sandoo Pharmaceuticals and Chemicals Recent Developments/Updates
Table 44. Nanjing Wedo Pharmatech Basic Information, Manufacturing Base and Competitors
Table 45. Nanjing Wedo Pharmatech Major Business
Table 46. Nanjing Wedo Pharmatech SuvorexantTablet Product and Services
Table 47. Nanjing Wedo Pharmatech SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 48. Nanjing Wedo Pharmatech Recent Developments/Updates
Table 49. Unibest Industrial Basic Information, Manufacturing Base and Competitors
Table 50. Unibest Industrial Major Business
Table 51. Unibest Industrial SuvorexantTablet Product and Services
Table 52. Unibest Industrial SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 53. Unibest Industrial Recent Developments/Updates
Table 54. Taizhou Sci-Healthoo Pharmaceutical Technology Basic Information, Manufacturing Base and Competitors
Table 55. Taizhou Sci-Healthoo Pharmaceutical Technology Major Business
Table 56. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Product and Services
Table 57. Taizhou Sci-Healthoo Pharmaceutical Technology SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 58. Taizhou Sci-Healthoo Pharmaceutical Technology Recent Developments/Updates
Table 59. Shanghai Haoyuan Chemexpress Basic Information, Manufacturing Base and Competitors
Table 60. Shanghai Haoyuan Chemexpress Major Business
Table 61. Shanghai Haoyuan Chemexpress SuvorexantTablet Product and Services
Table 62. Shanghai Haoyuan Chemexpress SuvorexantTablet Sales Quantity (KTablets), Average Price (US$/Tablet), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 63. Shanghai Haoyuan Chemexpress Recent Developments/Updates
Table 64. Global SuvorexantTablet Sales Quantity by Manufacturer (2021-2026) & (KTablets)
Table 65. Global SuvorexantTablet Revenue by Manufacturer (2021-2026) & (USD Million)
Table 66. Global SuvorexantTablet Average Price by Manufacturer (2021-2026) & (US$/Tablet)
Table 67. Market Position of Manufacturers in SuvorexantTablet, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 68. Head Office and SuvorexantTablet Production Site of Key Manufacturer
Table 69. SuvorexantTablet Market: Company Product Type Footprint
Table 70. SuvorexantTablet Market: Company Product Application Footprint
Table 71. SuvorexantTablet New Market Entrants and Barriers to Market Entry
Table 72. SuvorexantTablet Mergers, Acquisition, Agreements, and Collaborations
Table 73. Global SuvorexantTablet Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 74. Global SuvorexantTablet Sales Quantity by Region (2021-2026) & (KTablets)
Table 75. Global SuvorexantTablet Sales Quantity by Region (2027-2032) & (KTablets)
Table 76. Global SuvorexantTablet Consumption Value by Region (2021-2026) & (USD Million)
Table 77. Global SuvorexantTablet Consumption Value by Region (2027-2032) & (USD Million)
Table 78. Global SuvorexantTablet Average Price by Region (2021-2026) & (US$/Tablet)
Table 79. Global SuvorexantTablet Average Price by Region (2027-2032) & (US$/Tablet)
Table 80. Global SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 81. Global SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 82. Global SuvorexantTablet Consumption Value by Type (2021-2026) & (USD Million)
Table 83. Global SuvorexantTablet Consumption Value by Type (2027-2032) & (USD Million)
Table 84. Global SuvorexantTablet Average Price by Type (2021-2026) & (US$/Tablet)
Table 85. Global SuvorexantTablet Average Price by Type (2027-2032) & (US$/Tablet)
Table 86. Global SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 87. Global SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 88. Global SuvorexantTablet Consumption Value by Application (2021-2026) & (USD Million)
Table 89. Global SuvorexantTablet Consumption Value by Application (2027-2032) & (USD Million)
Table 90. Global SuvorexantTablet Average Price by Application (2021-2026) & (US$/Tablet)
Table 91. Global SuvorexantTablet Average Price by Application (2027-2032) & (US$/Tablet)
Table 92. North America SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 93. North America SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 94. North America SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 95. North America SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 96. North America SuvorexantTablet Sales Quantity by Country (2021-2026) & (KTablets)
Table 97. North America SuvorexantTablet Sales Quantity by Country (2027-2032) & (KTablets)
Table 98. North America SuvorexantTablet Consumption Value by Country (2021-2026) & (USD Million)
Table 99. North America SuvorexantTablet Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Europe SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 101. Europe SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 102. Europe SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 103. Europe SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 104. Europe SuvorexantTablet Sales Quantity by Country (2021-2026) & (KTablets)
Table 105. Europe SuvorexantTablet Sales Quantity by Country (2027-2032) & (KTablets)
Table 106. Europe SuvorexantTablet Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Europe SuvorexantTablet Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Asia-Pacific SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 109. Asia-Pacific SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 110. Asia-Pacific SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 111. Asia-Pacific SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 112. Asia-Pacific SuvorexantTablet Sales Quantity by Region (2021-2026) & (KTablets)
Table 113. Asia-Pacific SuvorexantTablet Sales Quantity by Region (2027-2032) & (KTablets)
Table 114. Asia-Pacific SuvorexantTablet Consumption Value by Region (2021-2026) & (USD Million)
Table 115. Asia-Pacific SuvorexantTablet Consumption Value by Region (2027-2032) & (USD Million)
Table 116. South America SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 117. South America SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 118. South America SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 119. South America SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 120. South America SuvorexantTablet Sales Quantity by Country (2021-2026) & (KTablets)
Table 121. South America SuvorexantTablet Sales Quantity by Country (2027-2032) & (KTablets)
Table 122. South America SuvorexantTablet Consumption Value by Country (2021-2026) & (USD Million)
Table 123. South America SuvorexantTablet Consumption Value by Country (2027-2032) & (USD Million)
Table 124. Middle East & Africa SuvorexantTablet Sales Quantity by Type (2021-2026) & (KTablets)
Table 125. Middle East & Africa SuvorexantTablet Sales Quantity by Type (2027-2032) & (KTablets)
Table 126. Middle East & Africa SuvorexantTablet Sales Quantity by Application (2021-2026) & (KTablets)
Table 127. Middle East & Africa SuvorexantTablet Sales Quantity by Application (2027-2032) & (KTablets)
Table 128. Middle East & Africa SuvorexantTablet Sales Quantity by Country (2021-2026) & (KTablets)
Table 129. Middle East & Africa SuvorexantTablet Sales Quantity by Country (2027-2032) & (KTablets)
Table 130. Middle East & Africa SuvorexantTablet Consumption Value by Country (2021-2026) & (USD Million)
Table 131. Middle East & Africa SuvorexantTablet Consumption Value by Country (2027-2032) & (USD Million)
Table 132. SuvorexantTablet Raw Material
Table 133. Key Manufacturers of SuvorexantTablet Raw Materials
Table 134. SuvorexantTablet Typical Distributors
Table 135. SuvorexantTablet Typical Customers
LIST OF FIGURES
Figure 1. SuvorexantTablet Picture
Figure 2. Global SuvorexantTablet Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global SuvorexantTablet Revenue Market Share by Type in 2025
Figure 4. 5 mgTablets Examples
Figure 5. 10 mgTablets Examples
Figure 6. 15 mgTablets Examples
Figure 7. 20 mgTablets Examples
Figure 8. Other Examples
Figure 9. Global SuvorexantTablet Revenue by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Figure 10. Global SuvorexantTablet Revenue Market Share by Regulatory Status in 2025
Figure 11. Approved Originator Product Examples
Figure 12. Approved Generic Product Examples
Figure 13. Generic Under Filing Examples
Figure 14. Global SuvorexantTablet Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 15. Global SuvorexantTablet Revenue Market Share by Application in 2025
Figure 16. Sleep Onset Insomnia Examples
Figure 17. Sleep Maintenance Insomnia Examples
Figure 18. Mixed Insomnia Examples
Figure 19. Clinical Research Examples
Figure 20. Other Examples
Figure 21. Global SuvorexantTablet Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global SuvorexantTablet Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global SuvorexantTablet Sales Quantity (2021-2032) & (KTablets)
Figure 24. Global SuvorexantTablet Price (2021-2032) & (US$/Tablet)
Figure 25. Global SuvorexantTablet Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global SuvorexantTablet Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of SuvorexantTablet by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 SuvorexantTablet Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 SuvorexantTablet Manufacturer (Revenue) Market Share in 2025
Figure 30. Global SuvorexantTablet Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global SuvorexantTablet Consumption Value Market Share by Region (2021-2032)
Figure 32. North America SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 35. South America SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 37. Global SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global SuvorexantTablet Consumption Value Market Share by Type (2021-2032)
Figure 39. Global SuvorexantTablet Average Price by Type (2021-2032) & (US$/Tablet)
Figure 40. Global SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global SuvorexantTablet Revenue Market Share by Application (2021-2032)
Figure 42. Global SuvorexantTablet Average Price by Application (2021-2032) & (US$/Tablet)
Figure 43. North America SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America SuvorexantTablet Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America SuvorexantTablet Consumption Value Market Share by Country (2021-2032)
Figure 47. United States SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe SuvorexantTablet Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe SuvorexantTablet Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 55. France SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific SuvorexantTablet Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific SuvorexantTablet Consumption Value Market Share by Region (2021-2032)
Figure 63. China SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 66. India SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 69. South America SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America SuvorexantTablet Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America SuvorexantTablet Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa SuvorexantTablet Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa SuvorexantTablet Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 83. SuvorexantTablet Market Drivers
Figure 84. SuvorexantTablet Market Restraints
Figure 85. SuvorexantTablet Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of SuvorexantTablet in 2025
Figure 88. Manufacturing Process Analysis of SuvorexantTablet
Figure 89. SuvorexantTablet Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
Figure 1. SuvorexantTablet Picture
Figure 2. Global SuvorexantTablet Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global SuvorexantTablet Revenue Market Share by Type in 2025
Figure 4. 5 mgTablets Examples
Figure 5. 10 mgTablets Examples
Figure 6. 15 mgTablets Examples
Figure 7. 20 mgTablets Examples
Figure 8. Other Examples
Figure 9. Global SuvorexantTablet Revenue by Regulatory Status, (USD Million), 2021 & 2025 & 2032
Figure 10. Global SuvorexantTablet Revenue Market Share by Regulatory Status in 2025
Figure 11. Approved Originator Product Examples
Figure 12. Approved Generic Product Examples
Figure 13. Generic Under Filing Examples
Figure 14. Global SuvorexantTablet Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 15. Global SuvorexantTablet Revenue Market Share by Application in 2025
Figure 16. Sleep Onset Insomnia Examples
Figure 17. Sleep Maintenance Insomnia Examples
Figure 18. Mixed Insomnia Examples
Figure 19. Clinical Research Examples
Figure 20. Other Examples
Figure 21. Global SuvorexantTablet Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 22. Global SuvorexantTablet Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 23. Global SuvorexantTablet Sales Quantity (2021-2032) & (KTablets)
Figure 24. Global SuvorexantTablet Price (2021-2032) & (US$/Tablet)
Figure 25. Global SuvorexantTablet Sales Quantity Market Share by Manufacturer in 2025
Figure 26. Global SuvorexantTablet Revenue Market Share by Manufacturer in 2025
Figure 27. Producer Shipments of SuvorexantTablet by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 28. Top 3 SuvorexantTablet Manufacturer (Revenue) Market Share in 2025
Figure 29. Top 6 SuvorexantTablet Manufacturer (Revenue) Market Share in 2025
Figure 30. Global SuvorexantTablet Sales Quantity Market Share by Region (2021-2032)
Figure 31. Global SuvorexantTablet Consumption Value Market Share by Region (2021-2032)
Figure 32. North America SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 33. Europe SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 34. Asia-Pacific SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 35. South America SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 36. Middle East & Africa SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 37. Global SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 38. Global SuvorexantTablet Consumption Value Market Share by Type (2021-2032)
Figure 39. Global SuvorexantTablet Average Price by Type (2021-2032) & (US$/Tablet)
Figure 40. Global SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 41. Global SuvorexantTablet Revenue Market Share by Application (2021-2032)
Figure 42. Global SuvorexantTablet Average Price by Application (2021-2032) & (US$/Tablet)
Figure 43. North America SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 44. North America SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 45. North America SuvorexantTablet Sales Quantity Market Share by Country (2021-2032)
Figure 46. North America SuvorexantTablet Consumption Value Market Share by Country (2021-2032)
Figure 47. United States SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 51. Europe SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 52. Europe SuvorexantTablet Sales Quantity Market Share by Country (2021-2032)
Figure 53. Europe SuvorexantTablet Consumption Value Market Share by Country (2021-2032)
Figure 54. Germany SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 55. France SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 56. United Kingdom SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 57. Russia SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 58. Italy SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 59. Asia-Pacific SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 60. Asia-Pacific SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 61. Asia-Pacific SuvorexantTablet Sales Quantity Market Share by Region (2021-2032)
Figure 62. Asia-Pacific SuvorexantTablet Consumption Value Market Share by Region (2021-2032)
Figure 63. China SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 64. Japan SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 65. South Korea SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 66. India SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 67. Southeast Asia SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 68. Australia SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 69. South America SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 70. South America SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 71. South America SuvorexantTablet Sales Quantity Market Share by Country (2021-2032)
Figure 72. South America SuvorexantTablet Consumption Value Market Share by Country (2021-2032)
Figure 73. Brazil SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 74. Argentina SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 75. Middle East & Africa SuvorexantTablet Sales Quantity Market Share by Type (2021-2032)
Figure 76. Middle East & Africa SuvorexantTablet Sales Quantity Market Share by Application (2021-2032)
Figure 77. Middle East & Africa SuvorexantTablet Sales Quantity Market Share by Country (2021-2032)
Figure 78. Middle East & Africa SuvorexantTablet Consumption Value Market Share by Country (2021-2032)
Figure 79. Turkey SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 80. Egypt SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 81. Saudi Arabia SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 82. South Africa SuvorexantTablet Consumption Value (2021-2032) & (USD Million)
Figure 83. SuvorexantTablet Market Drivers
Figure 84. SuvorexantTablet Market Restraints
Figure 85. SuvorexantTablet Market Trends
Figure 86. Porters Five Forces Analysis
Figure 87. Manufacturing Cost Structure Analysis of SuvorexantTablet in 2025
Figure 88. Manufacturing Process Analysis of SuvorexantTablet
Figure 89. SuvorexantTablet Industrial Chain
Figure 90. Sales Channel: Direct to End-User vs Distributors
Figure 91. Direct Channel Pros & Cons
Figure 92. Indirect Channel Pros & Cons
Figure 93. Methodology
Figure 94. Research Process and Data Source
